Effect of a Multi-component Education Program on Salt Reduction in Adults
1 other identifier
interventional
311
1 country
2
Brief Summary
Excess salt intake is a major contributor to high blood pressure, the leading individual risk factor for cardiovascular events, such as stroke, myocardial infarction and heart failure. According to PHYSA study, salt intake in Portugal remains much higher (10.7 g) than recommended by the international health organisations, indicating the need for effective implementation of salt reduction interventions. In Portugal the main source of daily salt intake is added salt during cooking, and salt content in bread, cheese and processed meat. The objective of this study is to determine the effectiveness of a dietary education program tailored for salt reduction. To assess the effectiveness of the salt reduction program the investigator's will measure changes in salt consumption levels, by evaluating the 24 h urinary sodium excretion. This study is a consortium-initiated, randomised, simple-blinded, controlled trial designed to assess the effectiveness of a salt reduction program versus generic healthy lifestyle program in the Lisbon Metropolitan Area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2019
CompletedStudy Start
First participant enrolled
January 28, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2019
CompletedJanuary 13, 2020
January 1, 2020
7 months
January 28, 2019
January 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in 24-hour urinary sodium excretion
Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up.
12 weeks
Secondary Outcomes (4)
Change in systolic and diastolic blood pressure
12 week
Change in weight
12 week
Change in waist circumference
12 week
Change in salt content in foods purchased
12 weeks
Study Arms (2)
Salt reduction program
EXPERIMENTALSalt reduction program.
Healthy lifestyle program
ACTIVE COMPARATORHealthy lifestyle program.
Interventions
Dietary and behavioural change program, led by nutritionists, including low sodium dietary advice; use of aromatic herbs and spices in food instead of salt; motivational activities; food diaries; restrict salty processed foods; eat more fresh foods and seasoning advice; problem solving exercises; digital bulletins; individual counselling reinforced at each clinic visit and shopping counselling at local supermarket.
Participants receive an educational healthy lifestyle program that includes 1) methods to cook healthier and the Mediterranean diet based on a high intake of fresh fruit and, vegetables, beans, grain legumes, lentils, nuts, cereals, and olive oil as source of fat; moderate intake of fish, poultry, yoghurt and cheese, low intake of salt, red meat, processed meats and sugar; 2) physical activity; 3) drink more water and reducing alcohol consumption; and 4) sleep education.
Eligibility Criteria
You may qualify if:
- Adults between the ages of 20 and 70.
- Subjects with or without hypertension, not medicated or medicated with medication and diet stabilized for at least 3 weeks.
- Responsible for the purchase and confection of their meals.
- Available to comply with study protocol and sign informed consent.
You may not qualify if:
- Pregnant, breastfeeding or planning to become pregnant within the study period.
- Subjects with current or previous cardiovascular disease (ischemic cardiovascular disease, angina stable or unstable; myocardial infarction, stroke or symptomatic peripheral arteriosclerosis).
- Subjects with liver or kidney diseases or cancer.
- Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to cooperate during the study.
- Subjects with special dietary needs.
- Health condition that prevents compliance with study requirements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Academia Cuf Descobertaslead
- CUF Academic and Research Medical Centercollaborator
- José de Mello Saúdecollaborator
- Pingo Docecollaborator
- NOVA Medical Schoolcollaborator
Study Sites (2)
Hospital CUF Infante Santo
Lisbon, 1350-070, Portugal
Hospital CUF Descobertas
Lisbon, 1998-018, Portugal
Related Publications (4)
Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014 Jun;32(6):1211-21. doi: 10.1097/HJH.0000000000000162.
PMID: 24675681BACKGROUNDPolonia J, Monteiro J, Almeida J, Silva JA, Bertoquini S. High salt intake is associated with a higher risk of cardiovascular events: a 7.2-year evaluation of a cohort of hypertensive patients. Blood Press Monit. 2016 Oct;21(5):301-6. doi: 10.1097/MBP.0000000000000205.
PMID: 27495189BACKGROUNDPolonia J, Lobo MF, Martins L, Pinto F, Nazare J. Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population. J Hypertens. 2017 Mar;35(3):477-486. doi: 10.1097/HJH.0000000000001180.
PMID: 27898506BACKGROUNDMoreira-Rosario A, Ismael S, Barreiros-Mota I, Morais J, Rodrigues C, Castela I, Mendes IC, Soares MI, da Costa LS, Oliveira CB, Henriques T, Pinto P, Pita D, de Oliveira CM, Maciel J, Serafim T, Araujo J, Rocha JC, Pestana D, Silvestre MP, Marques C, Faria A, Polonia J, Calhau C. Empowerment-based nutrition interventions on blood pressure: a randomized comparative effectiveness trial. Front Public Health. 2023 Nov 13;11:1277355. doi: 10.3389/fpubh.2023.1277355. eCollection 2023.
PMID: 38026295DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge Polónia, PhD
CINTESIS, Faculty of Medicine of the University of Porto
- PRINCIPAL INVESTIGATOR
Conceição Calhau, PhD
NOVA Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2019
First Posted
February 5, 2019
Study Start
January 28, 2019
Primary Completion
September 6, 2019
Study Completion
September 6, 2019
Last Updated
January 13, 2020
Record last verified: 2020-01